ÐÂÎÅ×ÊѶ
ÕãÒ½¶ùÔºÍŶÓ×îÐÂÑо¿Ð§¹û£ºÊ¯É¼¼î¼×ÓÐÍûÖÎÁÆÌÇÄò²¡Éö²¡
ÈÕÆÚ£º
2024Äê10ÔÂ26ÈÕ 08:51
½üÆÚ£¬£¬£¬£¬£¬£¬£¬£¬ÓÉÕã½´óѧҽѧԺÁ¥Êô¶ùͯҽԺÉöÄÚ¿ÆÍŶÓÓëaggame¹ÙÍøÏàÖú¿ªÕ¹µÄʯɼ¼î¼×ÖÎÁÆÌÇÄò²¡Éö²¡µÄ¶à×éѧÆÊÎöÑо¿½ÒÏþÁË×îÐÂÑо¿Ð§¹û£¬£¬£¬£¬£¬£¬£¬£¬Ñо¿Åú×¢Îúʯɼ¼î¼×ÔÚ¼õÇáÌÇÄò²¡ÓÕµ¼µÄÉöËðÉË¡¢Ö¬ÖÊ´úлÔÓÂÒºÍÑ×Ö¢·½ÃæÏÔʾ³öÓÐÏ£ÍûµÄÖÎÁƹ¦Ð§¡£¡£¡£¡£¡£¡£¡£¡£¸ÃÑо¿ÒѽÒÏþÓÚ¡¶Pharmacological Research¡·ÔÓÖ¾£¬£¬£¬£¬£¬£¬£¬£¬È«ÃûΪ“Huperzine A targets Apolipoprotein E: A potential therapeutic drug for diabetic nephropathy based on omics analysis”¡£¡£¡£¡£¡£¡£¡£¡£
ÔçÔÚ2020Ä꣬£¬£¬£¬£¬£¬£¬£¬Õã½´óѧҽѧԺÁ¥Êô¶ùͯҽԺ¾ÍÓëaggame¹ÙÍøÏàÖú¿ªÕ¹¹ýÑÎËáä强ÐÂÆ¬¶Ô¶ùͯÐÂÐ͹Ú×´²¡¶¾Ñ¬È¾µÄÁÆÐ§¼°Çå¾²ÐÔÆÀ¼ÛÑо¿¡£¡£¡£¡£¡£¡£¡£¡£ÏÖÔÚÔÙ´ÎÁªÊÖ£¬£¬£¬£¬£¬£¬£¬£¬ÓÖÔÚÐµļ²²¡ÁìÓòÈ¡µÃÁËϲÈ˵ÄЧ¹û¡£¡£¡£¡£¡£¡£¡£¡£
ʯɼ¼î¼×£º×ÔÈ»À¡ÔùµÄ¶àÃæÄÜÊÖ
ʯɼ¼î¼×(Huperzine A£¬£¬£¬£¬£¬£¬£¬£¬Hup A)×÷ΪÑÇÖÞÖ²ÎïÉß×ãʯɼµÄÌáÈ¡ÎïÁÙ´²Ö÷ÒªÓÃÓÚÉñ¾ÍËÐÐÐÔ²¡ÖÎÁÆ£¬£¬£¬£¬£¬£¬£¬£¬µ«½üÄêÀ´Ñо¿·¢Ã÷ÆäÔÚÌÇÄò²¡ÊÓÍøÄ¤²¡±äÖоßÓÐÏÔÖøµÄ½µÑªÌǺͿ¹Ñ××÷Óᣡ£¡£¡£¡£¡£¡£¡£µ«Æä¸üÆÕ±éµÄ±£»£»£»£»£»¤×÷Ó㬣¬£¬£¬£¬£¬£¬£¬ÌØÊâÊǶÔÌÇÄò²¡ÁíÒ»²¢·¢Ö¢ÌÇÄò²¡Éö²¡Éö¹¦Ð§µÄ±£»£»£»£»£»¤×÷ÓÃÈÔδ±»Ñо¿¡£¡£¡£¡£¡£¡£¡£¡£
ÌÇÄò²¡Éö²¡£¡£¡£¡£¡£¡£¡£¡£ºÇÄȻDZÔڵĿµ½¡É±ÊÖ
ÌÇÄò²¡£¡£¡£¡£¡£¡£¡£¡£¨DM£©×÷Ϊ³£¼û²¡¡¢¶à·¢²¡£¡£¡£¡£¡£¡£¡£¡£¬£¬£¬£¬£¬£¬£¬£¬ÊÇÑÏÖØÍþвÈËÀ࿵½¡µÄÌìÏÂÐÔ¹«¹²ÎÀÉúÎÊÌâ¡£¡£¡£¡£¡£¡£¡£¡£ÏÖÔÚÔÚÌìϹæÄ£ÄÚ£¬£¬£¬£¬£¬£¬£¬£¬ÌÇÄò²¡»¼²¡Âʺͻ¼²¡ÈËÊý¼±¾çÉÏÉý£¬£¬£¬£¬£¬£¬£¬£¬¾Ý¹ú¼ÊÌÇÄò²¡Í¬ÃË£¨IDF£©Í³¼Æ£º2021ÄêÈ«Çò³ÉÄêÌÇÄò²¡ÈËÊýÒÑ´ï5.37ÒÚ£¬£¬£¬£¬£¬£¬£¬£¬½Ï2019ÄêÔöÌí½ü16%£¬£¬£¬£¬£¬£¬£¬£¬Ô¤¼Æµ½2045ÄêÈ«ÇòÌÇÄò²¡»¼²¡×ÜÈËÊý½«µÖ´ï7.83ÒÚ£»£»£»£»£»2021ÄêÈ«ÇòÒòÌÇÄò²¡éæÃüÈËÊý´ï670Íò¡£¡£¡£¡£¡£¡£¡£¡£
½ü40¶àÄêÀ´£¬£¬£¬£¬£¬£¬£¬£¬Ëæ×ÅÎÒ¹ú¾¼Ã¸ßËÙÉú³¤¡¢ÉúÑÄ·½·¨Î÷·½»¯¡¢¶¼»á»¯ºÍÉú³ÝÀÏÁ仯¡¢·ÊÅÖÂÊÉÏÉý£¬£¬£¬£¬£¬£¬£¬£¬ÎÒ¹úÌÇÄò²¡»¼²¡ÂÊÒ²³Ê¿ìËÙÔöÌíÇ÷ÊÆ£º1980ÄêÎÒ¹ú³ÉÈËÌÇÄò²¡»¼²¡ÂÊΪ0.67%£¬£¬£¬£¬£¬£¬£¬£¬2007 Äê´ï9.7%£¬£¬£¬£¬£¬£¬£¬£¬2017Äê¸ü¸ß´ï 11.7%¡£¡£¡£¡£¡£¡£¡£¡£ÌÇÄò²¡Ç°ÆÚµÄ±ÈÀý¸ü¸ß¡£¡£¡£¡£¡£¡£¡£¡£¸üΪÑÏÖØµÄÊÇÎÒ¹úÔ¼ÓÐ50%µÄÌÇÄò²¡Î´±»Õï¶Ï£»£»£»£»£»°ÕÁ˽ÓÊÜÖÎÁÆÕߣ¬£¬£¬£¬£¬£¬£¬£¬ÌÇÄò²¡¿ØÖÆ×´Ì¬Ò²²»²ÇÏë¡£¡£¡£¡£¡£¡£¡£¡£IDFÊý¾ÝÏÔʾ£¬£¬£¬£¬£¬£¬£¬£¬×èÖ¹2021ÄêÎÒ¹ú³ÉÈËÌÇÄò²¡ÊýĿΪ1.41ÒÚ¡£¡£¡£¡£¡£¡£¡£¡£ÎÒ¹úÒÑÈ»³ÉΪȫÌìÏÂÌÇÄò²¡»¼Õß×î¶àµÄ¹ú¼Ò¡£¡£¡£¡£¡£¡£¡£¡£
¶øÌÇÄò²¡Éö²¡(diabetic nephropathy£¬£¬£¬£¬£¬£¬£¬£¬DN)ÊÇÌÇÄò²¡×îÖ÷ÒªÇÒ×îÑÏÖØµÄ²¢·¢Ö¢Ö®Ò»£¬£¬£¬£¬£¬£¬£¬£¬·¢²¡»úÖÆÖØ´ó£¬£¬£¬£¬£¬£¬£¬£¬Éæ¼°Ñõ»¯Ó¦¼¤¡¢Ñ×Ö¢¡¢ÏËά»¯ºÍϸ°ûµòÍö£¬£¬£¬£¬£¬£¬£¬£¬ÁÙ´²ÌØÕ÷ΪһÁ¬ÐÔ°×ÂѰ×ÄòÉøÍ¸ÔöÌí£¬£¬£¬£¬£¬£¬£¬£¬ÉöСÇòÂ˹ýÂÊ£¨eGFR£©¾ÙÐÐÐÔϽµ£¬£¬£¬£¬£¬£¬£¬£¬×îÖÕÉú³¤ÎªÖÕÄ©ÆÚÉö²¡£¡£¡£¡£¡£¡£¡£¡£¨ESRD£©£¬£¬£¬£¬£¬£¬£¬£¬½ìʱÉöÔ๦Ч»ù±¾Ëðʧ£¬£¬£¬£¬£¬£¬£¬£¬ÑݱäΪÉöË¥½ß£¬£¬£¬£¬£¬£¬£¬£¬ÌåÄÚ·ºÆð´ó×Ú¶¾ËØ»ýÖü£¬£¬£¬£¬£¬£¬£¬£¬Ë®¡¢µç½âÖÊ¡¢Ëá¼îʧºâ£¬£¬£¬£¬£¬£¬£¬£¬ÖÂËÀÂʸߣ¬£¬£¬£¬£¬£¬£¬£¬Ê®·ÖΣÏÕ¡£¡£¡£¡£¡£¡£¡£¡£
¹ØÓÚÌÇÄò²¡Éö²¡£¡£¡£¡£¡£¡£¡£¡£¬£¬£¬£¬£¬£¬£¬£¬ÏÖÔÚµÄÁÙ´²ÖÎÁÆÈÔÒÔÔçÆÚ¿ØÖÆÑªÌÇ¡¢ÑªÑ¹ÎªÖ÷£¬£¬£¬£¬£¬£¬£¬£¬¾ÙÐÐÖÁÍíÆÚÔòÐèÒª½ÓÄÉ͸ÎöµÈÉöÔàÌæ»»ÁÆ·¨¾ÙÐÐÖÎÁÆ¡£¡£¡£¡£¡£¡£¡£¡£ÉÐÎÞÓÐÓõÄÒ©Îï¸ÉÔ¤ÊֶΡ£¡£¡£¡£¡£¡£¡£¡£
¶à×éѧÆÊÎö£ºÕ¹ÏÖʯɼ¼î¼×µÄ×÷ÓûúÖÆ
±¾´ÎÑо¿ÖУ¬£¬£¬£¬£¬£¬£¬£¬Ñо¿Ö°Ô±½ÓÄÉÁËת¼×é¡¢´úл×顢΢ÉúÎï×éºÍÍøÂçÒ©ÀíѧµÈ¶à×é±ð¶àѧ¿Æ×ÛºÏÆÊÎöÒªÁ죬£¬£¬£¬£¬£¬£¬£¬Ì½ÌÖÁËʯɼ¼î¼×¹ØÓÚÌÇÄò²¡Éö²¡µÄÖÎÁÆ×÷Óᣡ£¡£¡£¡£¡£¡£¡£Ñо¿Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬£¬£¬£¬Ê¯É¼¼î¼×Äܹ»Í¨¹ýµ÷¿ØApoEµÄ±í´ï£¬£¬£¬£¬£¬£¬£¬£¬Æðµ½±£»£»£»£»£»¤ÉöÔà¡¢µ÷Àí´úл¡¢¸ÄÉÆ³¦µÀ΢ÉúÎïȺ¡¢¸ÄÉÆÑ×Ö¢µÈ×÷Óᣡ£¡£¡£¡£¡£¡£¡£¸ÃÑо¿Ê×´ÎÌṩÁËʯɼ¼î¼×¶ÔDNÖÎÁÆ×÷ÓõÄÖ¤¾Ý£¬£¬£¬£¬£¬£¬£¬£¬Åúעʯɼ¼î¼×¿ÉÄÜͨ¹ý°ÐÏòµ÷¿ØApoE£¬£¬£¬£¬£¬£¬£¬£¬³ÉΪһÖÖDZÔÚµÄÔ¤·ÀºÍÖÎÁÆDNµÄÒ©Îï¡£¡£¡£¡£¡£¡£¡£¡£ÏêϸÈçÏ£º
1. ÉöÔà±£»£»£»£»£»¤×÷ÓãºÔÚÁÙ´²ÖУ¬£¬£¬£¬£¬£¬£¬£¬ÄòÂѰ×ÊÇÆÀ¹ÀÉö¹¦Ð§ºÍËðÉË¡¢ÌáÐÑÉöÔ༲²¡µÄÖ÷ÒªÖ¸±ê¡£¡£¡£¡£¡£¡£¡£¡£Ñо¿Åú×¢£¬£¬£¬£¬£¬£¬£¬£¬ÔÚÐÛÐÔSD´óÊó¸øÒ©Ê¯É¼¼î¼×ºó£¬£¬£¬£¬£¬£¬£¬£¬Óë±ÈÕÕµÄδʹÓÃʯɼ¼î¼×µÄDN´óÊóÏà±È£¬£¬£¬£¬£¬£¬£¬£¬Ê¹ÓÃÁËʯɼ¼î¼×µÄDN´óÊóÄòÂѰף¨uALB£©Ë®Æ½·ºÆð½µµÍ£¬£¬£¬£¬£¬£¬£¬£¬²¢ÇÒÆäÉöÔàÖ¸Êý£¨kidney index£©¡¢Ñª¼¡ôû£¨SCr£©¡¢ÄòËØµª£¨BUN£©Ë®Æ½½ÔÓиÄÉÆ¡£¡£¡£¡£¡£¡£¡£¡££¨ÈçÏÂͼ£©
£¨×¢£ºNCΪÕý³£´óÊ󣻣»£»£»£»DNΪ»¼DN´óÊ󣻣»£»£»£»DN+Hup AΪʹÓÃÊÇʯɼ¼î¼×µÄDN´óÊ󡣡£¡£¡£¡£¡£¡£¡££©


ÁíÍ⣬£¬£¬£¬£¬£¬£¬£¬´óÊóÉöСÇò£¨Glomerulus£©ºÍÉöС¹Ü£¨Renal tubule£©µÄ½á¹¹ËðÉËÔÚʯɼ¼î¼×ÖÎÁÆÏÂÒ²ÓÐËù¼õÇᣬ£¬£¬£¬£¬£¬£¬£¬Î¬³ÖÕý³£ÉöСÇòÂ˹ý¹¦Ð§Ëù±ØÐèµÄÉö²¡ÂѰף¨Nephrin£©ºÍ×ãÍ»ÂѰף¨Podocin£©µÄÂѰ×ÖÊˮƽÔÚʯɼ¼î¼×¸øÒ©ºóÒ²ÏÔÖø»ØÉý¡£¡£¡£¡£¡£¡£¡£¡£
±ÈÕÕδÓÃÒ©µÄDN´óÊ󣬣¬£¬£¬£¬£¬£¬£¬Ê¹ÓÃʯɼ¼î¼×ºóµÄ´óÊóÉöÔ๦Чָ±êÒÔ¼°½á¹¹ËðÉËÔÚʹÓÃʯɼ¼î¼×ºó»ù±¾¶¼ÓÐËù¸ÄÉÆ¡£¡£¡£¡£¡£¡£¡£¡£Òò´Ë¿ÉÒԵóö£¬£¬£¬£¬£¬£¬£¬£¬Ê¯É¼¼î¼×±£´æ×ŶÔÉöÔàµÄ±£»£»£»£»£»¤×÷Óᣡ£¡£¡£¡£¡£¡£¡£
2. »ùÒò±í´ïÓ°Ï죺ΪÁË̽Ë÷ʯɼ¼î¼×ÖÎÁÆDNµÄ·Ö×Ó»úÖÆ£¬£¬£¬£¬£¬£¬£¬£¬Ñо¿¶ÔÉöÔà×éÖ¯¾ÙÐÐÁËת¼×é²âÐòºÍ²î±ð±í´ï»ùÒò(DEG)ÆÊÎö¡£¡£¡£¡£¡£¡£¡£¡£Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬£¬£¬£¬ÔÚDN×éÖÐÏÔÖøÉϵ÷µÄApoEºÍApoC 2ÔÚʯɼ¼î¼×ÖÎÁƺóÏÔÖø½µµÍ¡£¡£¡£¡£¡£¡£¡£¡£
3. ´úлÎïµ÷Àí£ºÑо¿Í¨¹ýÖ÷ÒòËØÆÊÎö£¨PCA£©ºÍÆ«×îС¶þ³ËÅбðÆÊÎö£¨PLS-DA£©À´Ñо¿ÉöÔà´úлת±ä·¢Ã÷£¬£¬£¬£¬£¬£¬£¬£¬NC×éºÍDN×éµÄÑùÆ·¾ßÓÐÏÔ×ÅÊèÉ¢ÐÔ£¬£¬£¬£¬£¬£¬£¬£¬¶øDN+Hup AµÄÂþÑܸü¿¿½üNC×é¡£¡£¡£¡£¡£¡£¡£¡£ÕâÒ²¾ÍÒâζ×Å£¬£¬£¬£¬£¬£¬£¬£¬Ê¹ÓÃÁËʯɼ¼î¼×µÄDN´óÊóµÄÉöÔà´úлÏà±ÈÓÚδÓÃÒ©µÄDN´óÊ󣬣¬£¬£¬£¬£¬£¬£¬ÆäÉöÔà´úлԽ·¢¿¿½üÓÚÕý³£´óÊ󡣡£¡£¡£¡£¡£¡£¡£ÕâÅúעʯɼ¼î¼×ÖÎÁÆÒ»¶¨Ë®Æ½Éϻָ´ÁËDN´óÊóµÄ´úл¡£¡£¡£¡£¡£¡£¡£¡££¨ÈçÏÂͼ£©

4. ³¦µÀ΢ÉúÎïȺ¸ÄÉÆ£ºShannonÖ¸ÊýÊÇÆÀ¹À΢ÉúÎïȺÂä¶àÑùÐÔ»ò¸»ºñ¶ÈµÄ³£ÓÃÖ¸±ê£¬£¬£¬£¬£¬£¬£¬£¬ÊýÖµÔ½¸ßÅúעȺÂäµÄ¶àÑùÐÔÔ½¸ß£¬£¬£¬£¬£¬£¬£¬£¬¹ÊÑо¿ÓÃÆäÀ´ÆÀ¹Àʯɼ¼î¼×¶Ô´óÊ󳦵À΢ÉúÎïȺµÄÓ°Ïì¡£¡£¡£¡£¡£¡£¡£¡£Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬£¬£¬£¬DN×éµÄShannon¶àÑùÐÔÖ¸Êý½µµÍ£¬£¬£¬£¬£¬£¬£¬£¬¶øDN+Hup A×éµÄShannon¶àÑùÐÔÖ¸ÊýÔöÌí£¬£¬£¬£¬£¬£¬£¬£¬Åúעʯɼ¼î¼×´¦Öóͷ£µ÷ÀíÁË´óÊ󳦵À΢ÉúÎïȺ¶àÑùÐÔ¡£¡£¡£¡£¡£¡£¡£¡££¨ÈçÏÂͼ£©

ÁÙ´²ÒâÒ壺ApoE×÷ΪÉúÎï±ê¼ÇÎï
Ϊ̽ÌÖApoEÓëDNÏà¹ØÉúÎï±ê¼ÇÎïµÄÁÙ´²Ïà¹ØÐÔ£¬£¬£¬£¬£¬£¬£¬£¬Ñо¿ÄÉÈëÁË428ÀýDN»¼Õß¾ÙÐнøÒ»²½ÆÊÎö¡£¡£¡£¡£¡£¡£¡£¡£
ÌÇ»¯ÑªºìÂѰף¨HbA1c£©ÊÇѪÌÇ¿ØÖÆË®Æ½µÄÖ÷ÒªÖ¸±ê£¬£¬£¬£¬£¬£¬£¬£¬Í¨³£ÒÔΪ£¬£¬£¬£¬£¬£¬£¬£¬ÌÇ»¯ÑªºìÂѰ×Ũ¶È¿ÉÓÐÓõط´Ó¦ÒÑÍù8~12ÖÜÆ½¾ùѪÌÇˮƽ¡£¡£¡£¡£¡£¡£¡£¡£Ñо¿·¢Ã÷£¬£¬£¬£¬£¬£¬£¬£¬HbA1cÓëApoE³ÊÕýÏà¹Ø£¬£¬£¬£¬£¬£¬£¬£¬ÌáÐÑApoEµÄ±í´ïËæHbA1cˮƽµÄÉý¸ß¶øÔöÌí¡£¡£¡£¡£¡£¡£¡£¡£
ÔÚÉö¹¦Ð§·½Ã棬£¬£¬£¬£¬£¬£¬£¬ÔÚ¸ßÂѰ×ÄòˮƽÏ£¬£¬£¬£¬£¬£¬£¬£¬ApoE±í´ïÓë24 hÄòÂѰ×ˮƽ³ÊÇ¿ÕýÏà¹Ø£¬£¬£¬£¬£¬£¬£¬£¬Åú×¢Ëæ×ÅÂѰ×ÄòˮƽµÄÉý¸ß£¬£¬£¬£¬£¬£¬£¬£¬ApoE±í´ïÒ²Éý¸ß¡£¡£¡£¡£¡£¡£¡£¡£
ÁíÍ⣬£¬£¬£¬£¬£¬£¬£¬Ñо¿»¹·¢Ã÷£¬£¬£¬£¬£¬£¬£¬£¬ApoEÓëѪÇå°×ÂѰף¨ALB£©¡¢Ö¬ÖÊÉúÎï±ê¼ÇÎï¡¢Ñ×Ö¢±ê¼ÇÎÓÈÆäÊÇCRPºÍHsCRP£©µÈ¶¼±£´æ½ÏΪÏÔÖøµÄÏà¹ØÐÔ¡£¡£¡£¡£¡£¡£¡£¡££¨ÈçÏÂͼ£©

Ñо¿»¹¾ÙÐÐÁËApoEÇõÍÑéÖ¤£¬£¬£¬£¬£¬£¬£¬£¬Çõͺóµ¼ÖÂÑ×Ö¢¼õÇᡢϸ°ûÕ³¸½ÔöÌíºÍϸ°û»îÐÔÉý¸ß¡£¡£¡£¡£¡£¡£¡£¡£ÓëNC×éÏà±È£¬£¬£¬£¬£¬£¬£¬£¬ÇõÍ×éÖÐ×ÔÊÉÌå±ê¼ÇÎïLC 3B II/LC 3B IÂѰױí´ïÏÔÖø½µµÍ£¬£¬£¬£¬£¬£¬£¬£¬Åú×¢ÆÏÌÑÌÇÓÕµ¼¸ü¸ßµÄ×ÔÊÉˮƽ£¬£¬£¬£¬£¬£¬£¬£¬ÇõÍApoE½µµÍ×ÔÊÉˮƽ¡£¡£¡£¡£¡£¡£¡£¡£
ÍøÂçÒ©Àíѧ£ºÑé֤ʯɼ¼î¼×µÄ¶à°Ðµã×÷ÓÃ
ͨ¹ýÍøÂçÒ©ÀíѧÆÊÎö£¬£¬£¬£¬£¬£¬£¬£¬Ñо¿Ö°Ô±½øÒ»²½ÑéÖ¤ÁËʯɼ¼î¼×¿ÉÄÜͨ¹ý°ÐÏòµ÷¿Ø¶à¸öÓëDNÏà¹ØµÄ»ùÒòºÍ´úл;¾¶À´Ê©Õ¹×÷ÓÃ, ²¢ÇÒÄܹ»Í¨¹ý¿ØÖÆÏ¸°ûµòÍö¶øÆð±£»£»£»£»£»¤×÷Óᣡ£¡£¡£¡£¡£¡£¡£
½áÂÛ£ºÊ¯É¼¼î¼×µÄDZÁ¦ÓëδÀ´Ñо¿Æ«Ïò
¸ÃÑо¿Ê×´ÎÌṩÁËʯɼ¼î¼×¶ÔDNÖÎÁÆ×÷ÓõÄÖ¤¾Ý£¬£¬£¬£¬£¬£¬£¬£¬Åúעʯɼ¼î¼×¿ÉÄÜͨ¹ý°ÐÏòµ÷¿ØApoE£¬£¬£¬£¬£¬£¬£¬£¬³ÉΪһÖÖDZÔÚµÄÔ¤·ÀºÍÖÎÁÆDNµÄÒ©Îï¡£¡£¡£¡£¡£¡£¡£¡£Ö»¹ÜÑо¿È¡µÃÁËÁîÈ˹ÄÎèµÄЧ¹û£¬£¬£¬£¬£¬£¬£¬£¬µ«ÈÔÐè½øÒ»²½µÄÁÙ´²ÊÔÑéºÍ´ó¹æÄ£¶à×éѧÊý¾ÝÑéÖ¤À´ÆÀ¹Àʯɼ¼î¼×µÄÁÙ´²ÖÎÁÆÇ±ÄÜ¡£¡£¡£¡£¡£¡£¡£¡£
ÌÇÄò²¡Éö²¡µÄÖÎÁÆÊÇÒ»¸öÖØ´óµÄÀú³Ì£¬£¬£¬£¬£¬£¬£¬£¬µ«ÕâÏîÑо¿ÎªÎÒÃÇÌṩÁËеÄÊӽǺÍÏ£Íû¡£¡£¡£¡£¡£¡£¡£¡£Ëæ×ÅÑо¿µÄÉîÈ룬£¬£¬£¬£¬£¬£¬£¬ÎÒÃÇÆÚ´ýʯɼ¼î¼×Äܹ»³ÉΪÌÇÄò²¡»¼ÕßµÄи£Òô¡£¡£¡£¡£¡£¡£¡£¡£ÈÃÎÒÃÇÒ»Æð¹Ø×¢ÕâÒ»ÁìÓòµÄ×îÐÂÏ£Íû£¬£¬£¬£¬£¬£¬£¬£¬ÎªÌÇÄò²¡»¼Õß´øÀ´¸ü¶àµÄÏ£ÍûºÍÑ¡Ôñ¡£¡£¡£¡£¡£¡£¡£¡£
Ñо¿ÎÄÏ×ȪԴ£º

ÉùÃ÷£º
1.±¾ÐÂÎÅÖ¼ÔÚ·ÖÏíѧÊõÇ°ÑØ¶¯Ì¬£¬£¬£¬£¬£¬£¬£¬£¬½ö¹©Ò½ÁÆÎÀÉúרҵÈËÊ¿»ùÓÚѧÊõÄ¿µÄ²ÎÔÄ£¬£¬£¬£¬£¬£¬£¬£¬·Ç¹ã¸æÓÃ;¡£¡£¡£¡£¡£¡£¡£¡£
2.aggame¹ÙÍøÖÆÒ©²î³ØÈκÎÒ©Æ·ºÍ/»ò˳Ӧ֢×÷ÍÆ¼ö¡£¡£¡£¡£¡£¡£¡£¡£
Ïà¹ØÍÆ¼ö